First US leukemia patient dosed with Smart Immune’s investigational SMART101 cell therapy
23 janv. 2023 07h01 HE
|
Consilium Strategic Communications
First US leukemia patient dosed with Smart Immune’s investigational SMART101 cell therapy Phase I/II trial will assess safety and efficacy of SMART101 in accelerating immune reconstitution to...
4BIO Capital Portfolio Company Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement
06 déc. 2022 08h07 HE
|
Consilium Strategic Communications
Press Release 4BIO Capital Portfolio Company Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement Company’s proprietary end-to-end...
Patients will benefit if Europe modernizes its policy framework to reflect the distinct promise of cell and gene therapy, the Alliance for Regenerative Medicine will highlight in 29 November EU Parliament event
24 nov. 2022 04h30 HE
|
Consilium Strategic Communications
Patients will benefit if Europe modernizes its policy framework to reflect the distinct promise of cell and gene therapy, the Alliance for Regenerative Medicine will highlight in 29 November EU...
Achilles Therapeutics to present at the 39th Annual J.P. Morgan Healthcare Conference
07 janv. 2021 07h00 HE
|
Consilium Strategic Communications
Achilles Therapeutics to present at the 39th Annual J.P. Morgan Healthcare Conference London, UK 7 January 2021 – Achilles Therapeutics (“Achilles”), a clinical-stage biopharmaceutical company...
Immunocore Appoints Nobel Laureate Professor Sir Peter J. Ratcliffe as Non-Executive Director
15 oct. 2020 07h00 HE
|
Consilium Strategic Communications
PRESS RELEASE Immunocore Appoints Nobel Laureate Professor Sir Peter J. Ratcliffe as Non-Executive Director (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 15...
Immunocore Appoints Nobel Laureate Professor Sir Peter J. Ratcliffe as Non-Executive Director
15 oct. 2020 02h00 HE
|
Consilium Strategic Communications
PRESS RELEASE Immunocore Appoints Nobel Laureate Professor Sir Peter J. Ratcliffe as Non-Executive Director (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 15...
Helsinn signs exclusive distribution and license agreements with Blanver and Varifarma for Pracinostat in South America
02 sept. 2019 08h30 HE
|
Consilium Strategic Communications
Helsinn signs exclusive distribution and license agreements with Blanver and Varifarma for Pracinostat in South America Lugano, Switzerland, São Paulo, Brazil, and Buenos Aires,...
CMR Surgical raises $100 million in a Series B financing
04 juin 2018 02h00 HE
|
Consilium Strategic Communications
CMR Surgical Limited ("CMR Surgical" or the "Company") CMR Surgical raises $100 million in a Series B financing Europe’s largest medical device financing paves way to Versius® commercialisation ...
Helsinn announces EUR6 million investment in Helsinn Birex Pharmaceuticals to safeguard the quality and authenticity of its products
24 mai 2018 03h30 HE
|
Consilium Strategic Communications
Helsinn announces EUR6 million investment in Helsinn Birex Pharmaceuticals to safeguard the quality and authenticity of its products Lugano, Switzerland, May 24, 2018 – Helsinn, a Swiss...